{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:58:28Z","timestamp":1791305908996,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.thromres.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T07:01:56Z","timestamp":1379055716000},"page":"621-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis"],"prefix":"10.1016","volume":"132","author":[{"given":"Sa\u0161a","family":"An\u017eej Doma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Vu\u010dnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Bo\u017ei\u010d Mijovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polona","family":"Peternel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojca","family":"Stegnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.09.006_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hq0202.102318","article-title":"Female hormones and thrombosis","volume":"22","author":"Rosendaal","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0010","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2013.09.006_bb0015","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0049-3848(11)70009-3","article-title":"Epidemiology of the contraceptive pill and venous thromboembolism","volume":"127","author":"Hannaford","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2005.05612.x","article-title":"The measurement and application of thrombin generation","volume":"130","author":"Baglin","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-2141.2008.07267.x","article-title":"Thrombin generation testing in routine clinical practice: are we there yet?","volume":"142","author":"van Veen","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1160\/TH06-07-0408","article-title":"Thrombin generation, a function test of the haemostatic-thrombotic system","volume":"96","author":"Hemker","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0035","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2141.2007.06738.x","article-title":"Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence","volume":"138","author":"van Hylckama Vlieg","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation","volume":"296","author":"Hron","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2013.09.006_bb0045","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1373\/clinchem.2008.112243","article-title":"Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer","volume":"54","author":"Eichinger","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.thromres.2013.09.006_bb0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0049-3848(99)00092-4","article-title":"A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results","volume":"96","author":"He","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0049-3848(01)00332-2","article-title":"A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work","volume":"103","author":"He","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0060","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/j.1538-7836.2003.00451.x","article-title":"Increased hemostasis potential persists in women with previous thromboembolism with or without APC resistance","volume":"1","author":"Antovic","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1538-7836.2007.02362.x","article-title":"Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assay","volume":"5","author":"Curnow","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2006.08.005","article-title":"Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia","volume":"120","author":"Anzej","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0075","series-title":"Medical eligibility criteria for contraceptive use","year":"2009"},{"issue":"3","key":"10.1016\/j.thromres.2013.09.006_bb0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1423-0410.2008.01081.x","article-title":"The characterization and impact of microparticles on haemostasis within fresh-frozen plasma","volume":"95","author":"Lawrie","year":"2008","journal-title":"Vox Sang"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2013.09.006_bb0085","first-page":"S105","article-title":"Thrombophilia screening--at the right time, for the right patient, with a good reason","volume":"48","author":"Stegnar","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2013.09.006_bb0090","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0049-3848(11)70007-X","article-title":"Thrombin generation tests","volume":"127","author":"Castoldi","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0095","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1615646","article-title":"Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation","volume":"85","author":"Berckmans","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.thromres.2011.08.020","article-title":"Circulating microparticles and risk of venous thromboembolism","volume":"129","author":"Bucciarelli","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0030-1265294","article-title":"The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis","volume":"36","author":"Antovic","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0037-1616919","article-title":"Thrombin generation and venous thromboembolism","volume":"28","author":"Eichinger","year":"2008","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2013.09.006_bb0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1160\/TH09-06-0356","article-title":"Thrombin generation as an intermediate phenotype for venous thrombosis","volume":"103","author":"Segers","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0120","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.moh.0000130314.33410.d7","article-title":"Thrombin generation assays: accruing clinical relevance","volume":"11","author":"Hemker","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.thromres.2007.04.012","article-title":"The endogenous thrombin potential and the risk of venous thromboembolism","volume":"121","author":"Tripodi","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-3848(03)00067-7","article-title":"Overall haemostasis potential assays performed in thrombophilic plasma: the effect of preactivating protein C and antithrombin","volume":"108","author":"Andresen","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.09.006_bb0135","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1538-7836.2006.01857.x","article-title":"Activated partial thromboplastin time (APTT). New indications for an old test?","volume":"4","author":"Tripodi","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0140","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1182\/blood-2004-03-1042","article-title":"A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism","volume":"104","author":"Tripodi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.09.006_bb0145","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1538-7836.2006.01868.x","article-title":"Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time","volume":"4","author":"Hron","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.2006.06130.x","article-title":"Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal","volume":"134","author":"Legnani","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1515\/CCLM.2004.082","article-title":"The emerging value of P-selectin as a disease marker","volume":"42","author":"Kappelmayer","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.thromres.2013.09.006_bb0160","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1515\/CCLM.2010.335","article-title":"C-reactive protein and venous thromboembolism: causal or casual association?","volume":"48","author":"Lippi","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.thromres.2013.09.006_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0170","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"The P-selectin. tissue factor. coagulation triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0175","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/01.ATV.0000166521.90532.44","article-title":"New links between inflammation and thrombosis","volume":"25","author":"Wagner","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2013.09.006_bb0180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1076029611405032","article-title":"Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis","volume":"17","author":"Ramacciotti","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0185","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1160\/TH07-02-0115","article-title":"Circulating P-selectin and the risk of recurrent venous thromboembolism","volume":"97","author":"Kyrle","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0190","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","article-title":"High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"112","author":"Ay","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.09.006_bb0195","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2013.09.006_bb0200","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.09.006_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2005.1.1","article-title":"Venous thrombosis: the role of genes, environment, and behavior","author":"Rosendaal","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.thromres.2013.09.006_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0037-1615216","article-title":"Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives","volume":"80","author":"Bloemenkamp","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.09.006_bb0215","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/j.1538-7836.2005.01584.x","article-title":"Thrombin generation profiles in deep venous thrombosis","volume":"3","author":"Brummel-Ziedins","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813004064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813004064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T22:35:42Z","timestamp":1563921342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813004064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0049384813004064"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.09.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}